Nalichowski Adrian, Kaufman Isaac, Gallo John, Bossenberger Todd, Solberg Tim, Ramirez Ezequiel, Yan Yulong, Fredrick Julie, Bichay Tewfik, Mayville Alan, Burmeister Jay
Department of Oncology, Karmanos Cancer Institute, Detroit, MI, USA.
Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
J Appl Clin Med Phys. 2017 Jan;18(1):164-169. doi: 10.1002/acm2.12022. Epub 2016 Dec 29.
There are numerous commercial radiotherapy systems capable of delivering single fraction spine radiosurgery/SBRT. We aim to compare the capabilities of several of these systems to deliver this treatment when following standardized criteria from a national protocol. Four distinct target lesions representing various case presentations of spine metastases were contoured in both the thoracic and lumbar spine of an anthropomorphic SBRT phantom. Single fraction radiosurgery/SBRT plans were designed for each target with each of our treatment platforms. Plans were prescribed to 16 Gy in one fraction to cover 90% of the target volume using normal tissue and target constraints from RTOG 0631. We analyzed these plans with priority on the dose to 10% of the partial spinal cord and dose to 0.03 cc of the spinal cord. Each system was able to maintain 90% target coverage while meeting all the constraints of RTOG 0631. On average, CyberKnife was able to achieve the lowest spinal cord doses overall and also generated the sharpest dose falloff as indicated by the Paddick gradient index. Treatment times varied widely depending on the modality utilized. On average, treatment can be delivered faster with Flattening Filter Free RapidArc and Tomotherapy, compared to Vero and Cyberknife. While all systems analyzed were able to meet the dose constraints of RTOG 0631, unique characteristics of individual treatment modalities may guide modality selection. Specifically, certain modalities performed better than the others for specific target shapes and locations, and delivery time varied significantly among the different modalities. These findings could provide guidance in determining which of the available modalities would be preferable for the treatment of spine metastases based on individualized treatment goals.
有许多商业放疗系统能够进行单次分割脊柱放射外科手术/立体定向体部放疗(SBRT)。我们的目标是按照国家方案的标准化标准,比较其中几种系统进行这种治疗的能力。在一个拟人化SBRT体模的胸椎和腰椎中勾勒出四个不同的靶病变,代表脊柱转移瘤的各种病例表现。使用我们的每个治疗平台为每个靶区设计单次分割放射外科手术/SBRT计划。根据RTOG 0631的正常组织和靶区限制条件,计划规定单次剂量为16 Gy,以覆盖90%的靶区体积。我们分析这些计划时,优先考虑脊髓10%部分的剂量和0.03 cc脊髓的剂量。每个系统都能够在满足RTOG 0631所有限制条件的同时保持90%的靶区覆盖。平均而言,射波刀总体上能够实现最低的脊髓剂量,并且如帕迪克梯度指数所示,产生最陡峭的剂量下降。治疗时间因所采用的方式而异。平均而言,与医科达直线加速器和螺旋断层放疗系统相比,采用无 flattening filter的容积弧形调强放疗(FFF RapidArc)和螺旋断层放疗系统可以更快地完成治疗。虽然分析的所有系统都能够满足RTOG 0631的剂量限制,但个别治疗方式的独特特性可能会指导方式的选择。具体而言,某些方式在特定的靶区形状和位置上比其他方式表现更好,并且不同方式之间的治疗时间差异显著。这些发现可以为根据个体化治疗目标确定哪种可用方式更适合治疗脊柱转移瘤提供指导。